Primary and secondary analyses of emergent drug resistance through week 48 from the STaR Study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF single-tablet regimens
ANTIVIRAL THERAPY（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要